Development and Psychometric Testing of HPV Knowledge Scale
NCT ID: NCT06466252
Last Updated: 2024-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
673 participants
OBSERVATIONAL
2023-02-01
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Knowledge and Attitude About HPV Vaccines
NCT01043341
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
NCT06397378
Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
NCT06743880
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women
NCT02464358
Prevention of HPV in the School Health Service
NCT02280967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants (parents) were recruited from 5 elementary schools. According to a minimum sample size estimation for a psychometric study, it needs 10 times the total number of items (Boateng, 2018). the total participants, 52 items x 10= 520 participants were required.
The researchers got approval from schools to invite parents to attend the school of event invitations. Each participant came to the school where their child attended. Parents attended the regular meeting on the appointed day. at that time, researchers approached potential participants to explain to them the purpose of this study, participant rights, risks, and benefits. The researcher obtained participants' consent to participate in this research with a serial number.
During the process, researchers keep the participant anonymous. The questionnaires were distributed to the participants and took around 15-20 minutes to complete. All data was recapitulated and stored in Excel format. Data were kept by the researcher to maintain confidentiality. All data analyses were performed using SPSS software from IBM Corp.
Statistical analyses are below:
1. Descriptive analysis was used to identify population characteristics
2. Validity testing contains Exploratory and Confirmatory factor analyses were structure and construct.
3. Reliability testing was done using Cronbach alpha to determine the instrument's reliability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychometric Group
There are no interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants could speak Bahasa Indonesia fluently
* Participants live with their children in one house
* Participants are willing to participate in the study
Exclusion Criteria
* their children' age are over 14 years old.
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yudisa Diaz Lutfi Sandi
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elementary school
Ngawi, East Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol. 2018 Feb;26(2):158-168. doi: 10.1016/j.tim.2017.07.007. Epub 2017 Aug 17.
Li Y, Xu C. Human Papillomavirus-Related Cancers. Adv Exp Med Biol. 2017;1018:23-34. doi: 10.1007/978-981-10-5765-6_3.
Songane M, Grossmann V. The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value. PLoS One. 2021 Jan 11;16(1):e0244722. doi: 10.1371/journal.pone.0244722. eCollection 2021.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.
Garg A, Wheldon CW, Galvin AM, Moore JD, Griner SB, Thompson EL. The Development and Psychometric Evaluation of the Mid-adult Human Papillomavirus Vaccine Knowledge Scale in the United States. Sex Transm Dis. 2022 Jun 1;49(6):423-428. doi: 10.1097/OLQ.0000000000001615. Epub 2022 Feb 8.
Harrison SE, Yelverton V, Wang Y, Ostermann J, Fish LJ, Williams CL, Vasudevan L, Walter EB. Examining Associations between Knowledge and Vaccine Uptake Using the Human Papillomavirus Knowledge Questionnaire (HPV-KQ). Am J Health Behav. 2021 Sep 30;45(5):810-827. doi: 10.5993/AJHB.45.5.2.
Waller J, Ostini R, Marlow LA, McCaffery K, Zimet G. Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med. 2013 Jan;56(1):35-40. doi: 10.1016/j.ypmed.2012.10.028. Epub 2012 Nov 8.
Trevisol FS, Nunes RD, Parma GOC, Manoel AL, Zapelini CM, Trevisol DJ, Traebert J. Internal construct validity of the Brazilian version of a tool for assessing the population's knowledge of human papillomavirus. Rev Bras Epidemiol. 2020 Jun 5;23:e200054. doi: 10.1590/1980-549720200054. eCollection 2020.
Sethi S, Santiago PHR, Soares GH, Ju X, Antonsson A, Canfell K, Smith M, Garvey G, Hedges J, Jamieson L. Development and validation of an HPV infection knowledge assessment scale among Aboriginal and Torres Strait Islander Peoples. Vaccine X. 2023 May 24;14:100317. doi: 10.1016/j.jvacx.2023.100317. eCollection 2023 Aug.
Grace-Leitch L, Shneyderman Y. Using the Health Belief Model to Examine the Link between HPV Knowledge and Self-Efficacy for Preventive Behaviors of Male Students at a Two-Year College in New York City. Behav Med. 2016 Jul-Sep;42(3):205-10. doi: 10.1080/08964289.2015.1121131.
Guvenc G, Seven M, Akyuz A. Health Belief Model Scale for Human Papilloma Virus and its Vaccination: Adaptation and Psychometric Testing. J Pediatr Adolesc Gynecol. 2016 Jun;29(3):252-8. doi: 10.1016/j.jpag.2015.09.007. Epub 2015 Sep 26.
Krawczyk A, Perez S, King L, Vivion M, Dube E, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother. 2015;11(2):330-6. doi: 10.4161/21645515.2014.980708.
Sinshaw MT, Berhe S, Ayele SG. Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia. Infect Drug Resist. 2022 Mar 3;15:781-793. doi: 10.2147/IDR.S352440. eCollection 2022.
Pelullo CP, Di Giuseppe G, Angelillo IF. Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy. PLoS One. 2012;7(8):e42856. doi: 10.1371/journal.pone.0042856. Epub 2012 Aug 8.
Ojeaga A, Alema-Mensah E, Rivers D, Azonobi I, Rivers B. Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA. J Cancer Educ. 2019 Feb;34(1):66-72. doi: 10.1007/s13187-017-1268-6.
Forster AS, McBride KA, Davies C, Stoney T, Marshall H, McGeechan K, Cooper SC, Skinner SR. Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health. 2017 Jun;147:77-83. doi: 10.1016/j.puhe.2017.02.006. Epub 2017 Mar 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
421/061/404.102.28/II/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.